PARLIAMENTARY WRITTEN QUESTION
Coronavirus: Vaccination (17 January 2023)
Question Asked
Asked by:
Navendu Mishra (Labour)
Answer
We remain in regular discussion with Moderna and Pfizer/BioNTech on future COVID-19 vaccine supply. We are unable to provide the information requested on costing, as it is commercially sensitive. Moderna and Pfizer/BioNTech continue to negotiate vaccine deals with countries across the world and their ability to negotiate and compete is contingent on pricing information being kept confidential.
Answered by:
Maria Caulfield (Conservative)
23 January 2023
Contains Parliamentary information licensed under the Open Parliament Licence v3.0.